ArticleNeoplasia (New York, N.Y.)2025

Targeting Wnt/β-catenin signaling enhances the efficacy of anti-CD38 immunotherapy in multiple myeloma.

Heng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.